Home / Health / Weight Loss Injections Linked to Scurvy Risk
Weight Loss Injections Linked to Scurvy Risk
11 Feb
Summary
- GLP-1 weight loss drugs may increase risk of scurvy.
- Appetite suppression can lead to nutrient deficiencies.
- Scurvy symptoms include fatigue, bleeding gums, and pain.
Dieticians are raising concerns that popular GLP-1 weight loss injections could put users at risk of scurvy, a severe vitamin C deficiency. This Victorian-era disease is reportedly seeing a resurgence, with recent data indicating a 25% rise in cases since 2007, largely attributed to poor diets. Weight loss drugs, including those like Wegovy and Mounjaro, function by suppressing appetite. However, this restriction can lead to inadvertent malnutrition, with patients missing vital nutrients.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
